Open-Cavity, Reduced-Pressure Treatment Devices And Systems

Patent metadata

Field	Value
Publication number	US-2019282405-A1
Application number	US-201916431430-A
Country	US
Kind code	A1
Filing date	Jun 4, 2019
Priority date	Oct 29, 2008
Publication date	Sep 19, 2019
Grant date	—

Abstract

An open-cavity, reduced-pressure treatment device and system for treating a cavity in a patient's body, such as an abdominal cavity, is presented. In one instance, an open-cavity, reduced-pressure treatment device includes a plurality of encapsulated leg members, each having an interior portion with a leg manifold member and formed with fenestrations operable to allow fluid flow into the interior portion, and a central connection member fluidly coupled to the plurality of encapsulated leg members. The central connection member has a connection manifold member. The open-cavity, reduced-pressure treatment devices, systems, and methods allow for, among other things, removal of fluids.

First claim

We claim:

1 . A treatment device, comprising:
a central fluid hub having an upper surface and a lower surface, the fluid hub including a foam manifold defining at least a portion of the upper surface and a substantially fluid impermeable wall defining at least a portion of the lower surface, the fluid impermeable wall including a plurality of apertures; and a plurality of elongate members having a proximal end, a distal end, an upper surface, and a lower surface, the elongate members including a foam enclosed within a substantially fluid impermeable wall material, the proximal ends of the plurality of elongate members in fluid communication with the central fluid hub, the elongate members including apertures extending through the substantially fluid impermeable wall material along at least a portion of the lower surface of the elongate members.

2 . The treatment device of claim 1 , wherein:
the plurality of elongate members have a length extending from the central fluid hub and a first width generally parallel to the upper surface; the central fluid hub has a second width between a first elongate member and a second elongate member; the second width is greater than the first width; and an aspect ratio of the plurality of elongate members is in the range of 3.0 to 10.0.

3 . The treatment device of claim 1 , wherein:
the plurality of elongate members have a length extending from the central fluid hub and a first width generally parallel to the upper surface; the central fluid hub has a second width between a first elongate member and a second elongate member; the second width is greater than the first width; and an aspect ratio of the plurality of elongate members is greater than 3.5.

4 . The treatment device of claim 1 , further comprising a substantially fluid impermeable material extending between the plurality of elongate members.

5 . The treatment device of claim 1 , further comprising an expandable material extending between the plurality of elongate members.

6 . The treatment device of claim 1 , wherein the central fluid hub and the plurality of elongate fluid members are configured to be disposed adjacent to a tissue site.

7 . The treatment device of claim 1 , wherein the lower surface of the plurality of elongate members is configured to substantially contact a tissue site along a length of the elongate member.

8 . A treatment device, comprising:
a fluid hub including an upper surface, a lower surface, a foam manifold, and a substantially fluid impermeable wall defining at least a portion of the lower surface, the fluid impermeable wall including a plurality of apertures; and a plurality of elongate members including an upper surface, a lower surface, and a foam enclosed within a substantially fluid impermeable wall material, the plurality of elongate members in fluid communication with the fluid hub and including apertures extending through the substantially fluid impermeable wall material along at least a portion of the lower surface of the elongate members; wherein the lower surface of the plurality of elongate members is configured to substantially contact a tissue site along a length of the elongate member.

9 . The treatment device of claim 8 , wherein:
the plurality of elongate members have a length extending from the fluid hub and a first width generally parallel to the upper surface; the fluid hub has a second width between a first elongate member and a second elongate member; the second width is greater than the first width; and an aspect ratio of the plurality of elongate members is in the range of 3.0 to 10.0.

10 . The treatment device of claim 8 , wherein:
the plurality of elongate members have a length extending from the fluid hub and a first width generally parallel to the upper surface; the fluid hub has a second width between a first elongate member and a second elongate member; the second width is greater than the first width; and an aspect ratio of the plurality of elongate members is greater than 3.5.

11 . The treatment device of claim 8 , further comprising a substantially fluid impermeable material extending between the plurality of elongate members.

12 . The treatment device of claim 8 , further comprising an expandable material extending between the plurality of elongate members.

13 . The treatment device of claim 8 , wherein the fluid hub and the plurality of elongate fluid members are configured to be disposed adjacent to a tissue site.

14 . The treatment device of claim 8 , wherein the foam manifold defines at least a portion of the upper surface of the fluid hub.

Assignees

• Kci Licensing Inc

Inventors

• Hardman Ian James
• Whyte David George
• Locke Christopher Brian
• Robinson Timothy Mark
• Sealy James Joseph
• Hall Colin John
• Beard Mark Stephen James

Classifications

• A61M2210/1021

  Abdominal cavity · CPC title

• Y10T156/1057

  Subsequent to assembly of laminae · CPC title

• Y10T156/1062

  Prior to assembly · CPC title

• Y10T156/1052

  with cutting, punching, tearing or severing · CPC title

• Y10T156/1056

  Perforating lamina · CPC title